TXG|10X Genomics Inc|가격:18.610|Chg%:0.91

자세한 내용은 10X Genomics Inc 회사

10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.

10X Genomics Inc 정보



종목 코드 TXG

회사 이름10X Genomics Inc

상장일Sep 12, 2019

CEOSaxonov (Serge Wilson)

직원 수1306

유형Ordinary Share

회계 연도 종료Sep 12

주소6230 Stoneridge Mall Road

도시PLEASANTON

증권 거래소NASDAQ OMX - NASDAQ BASIC

국가United States of America

우편 번호94588

전화19254017300

웹사이트https://www.10xgenomics.com/

종목 코드 TXG

상장일Sep 12, 2019

CEOSaxonov (Serge Wilson)

10X Genomics Inc의 회사 임원진



이름

이름/직위

직위

주식 보유

변동

Mr. Serge Wilson Saxonov, Ph.D.

Chief Executive Officer, Co-Founder, Director

1.09M

+50000.00%

Dr. John R. Stuelpnagel

Independent Chairman of the Board

369.61K

+15357.00%

Whitaker (Eric S)

Chief Legal Officer

202.20K

+45563.00%

Mr. Sridhar (Sri) Kosaraju

Independent Director

59.45K

+15357.00%

Dr. Benjamin J. Hindson, Ph.D.

President, Co-Founder, Chief Scientific Officer, Director

36.41K

-8283.00%

Ms. Kimberly J. (Kim) Popovits

Independent Director

28.62K

+15357.00%

Dr. Shehnaaz Suliman, M.D.

Independent Director

28.62K

+15357.00%

Mr. Alan V. Mateo

Independent Director

--

Dr. Sarah A. Teichmann

Independent Director

--

Mr. Adam S. Taich

Chief Financial Officer

--

이름

이름/직위

직위

주식 보유

변동

Mr. Serge Wilson Saxonov, Ph.D.

Chief Executive Officer, Co-Founder, Director

1.09M

+50000.00%

Dr. John R. Stuelpnagel

Independent Chairman of the Board

369.61K

+15357.00%

Whitaker (Eric S)

Chief Legal Officer

202.20K

+45563.00%

Mr. Sridhar (Sri) Kosaraju

Independent Director

59.45K

+15357.00%

Dr. Benjamin J. Hindson, Ph.D.

President, Co-Founder, Chief Scientific Officer, Director

36.41K

-8283.00%

Ms. Kimberly J. (Kim) Popovits

Independent Director

28.62K

+15357.00%

수익 분석

통화: USD마지막 업데이트: Tue, Jan 6

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

사업별USD

이름

수익

비율

Consumables

127.89M

85.83%

Instruments

12.00M

8.05%

Services

8.13M

5.45%

License and royalty revenue

983.00K

0.66%

지역별USD

이름

수익

비율

United States

77.25M

51.84%

Europe, the Middle East and Africa

41.62M

27.94%

China

15.19M

10.19%

Asia Pacific

12.32M

8.27%

Americas

2.63M

1.76%

사업별

지역별

사업별USD

이름

수익

비율

Consumables

127.89M

85.83%

Instruments

12.00M

8.05%

Services

8.13M

5.45%

License and royalty revenue

983.00K

0.66%

주식 보유 통계

마지막 업데이트: Wed, Nov 19

주주

주주 유형

주주

비율

The Vanguard Group, Inc.

11.16%

ARK Investment Management LLC

10.21%

BlackRock Institutional Trust Company, N.A.

6.68%

Fidelity Management & Research Company LLC

6.19%

Sumitomo Mitsui Trust Bank, Limited

4.72%

기타

61.05%

주주

비율

The Vanguard Group, Inc.

11.16%

ARK Investment Management LLC

10.21%

BlackRock Institutional Trust Company, N.A.

6.68%

Fidelity Management & Research Company LLC

6.19%

Sumitomo Mitsui Trust Bank, Limited

4.72%

기타

61.05%

주주 유형

주주

비율

Investment Advisor

52.87%

Investment Advisor/Hedge Fund

27.36%

Hedge Fund

13.85%

Research Firm

6.25%

Bank and Trust

5.11%

Venture Capital

1.88%

Individual Investor

1.84%

Family Office

0.90%

Pension Fund

0.53%

기관 주식 보유



마지막 업데이트: Thu, Jan 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q4

700

125.80M

108.01%

-15.13M

2025Q3

675

117.21M

102.45%

-24.61M

2025Q2

669

120.42M

108.39%

-15.20M

2025Q1

687

115.67M

104.27%

-8.84M

2024Q4

689

107.08M

98.92%

-12.41M

2024Q3

682

106.90M

100.39%

-9.08M

2024Q2

691

105.36M

99.70%

-5.09M

2024Q1

762

106.36M

101.17%

-3.12M

2023Q4

817

100.80M

96.01%

-9.73M

2023Q3

835

96.86M

93.80%

-12.55M

주주 활동



이름

보유 주식

비율

변동

Chg %

날짜

The Vanguard Group, Inc.

13.25M

11.38%

+834.27K

+6.72%

Sep 30, 2025

ARK Investment Management LLC

11.89M

10.21%

-2.00M

-14.43%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

7.78M

6.68%

+194.98K

+2.57%

Sep 30, 2025

Fidelity Management & Research Company LLC

7.21M

6.19%

-430.91K

-5.64%

Sep 30, 2025

Sumitomo Mitsui Trust Bank, Limited

5.38M

4.62%

-636.74K

-10.58%

Sep 30, 2025

Millennium Management LLC

5.44M

4.67%

+2.55M

+88.57%

Sep 30, 2025

Amova Asset Management Co., Ltd.

5.38M

4.62%

+5.38M

--

Sep 30, 2025

Wellington Management Company, LLP

4.29M

3.68%

+2.39M

+126.60%

Sep 30, 2025

Quantinno Capital Management LP

3.49M

3%

+1.26M

+56.37%

Sep 30, 2025

BofA Global Research (US)

3.30M

2.83%

+393.85K

+13.55%

Sep 30, 2025

주식 배당금



지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.

날짜

배당금

기준일

지급일

배당락일

데이터 없음

주식 분할



날짜

배당락일

유형

비율

데이터 없음

날짜

배당락일

유형

비율

데이터 없음

10X Genomics Inc

자세한 내용은 10X Genomics Inc 회사

10X Genomics Inc 정보

10X Genomics Inc의 회사 임원진

수익 분석

주식 보유 통계

기관 주식 보유

주주 활동

관련 ETF

주식 배당금

주식 분할